Manning Meredith Insider Trades

Insider Trading History

Track insider trading activity for Manning Meredith. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
May 18, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$11.5M 217,507 shares
$53.01
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $3.56M 67,165 shares
Last Trade
Mar 27, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$229k 7,522 shares
$30.44
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $3.82M 72,029 shares
Last Trade
Jan 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.67M 61,400 shares
$43.56
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $2.3M 43,429 shares
Last Trade
Dec 15, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$96k 1,922 shares
$49.95
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $2.81M 52,932 shares
Last Trade
Mar 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.04M 45,249 shares
$67.28
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $4.82M 91,000 shares
Last Trade
Mar 27, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.49M 37,000 shares
$67.39
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $4.37M 82,351 shares
Last Trade
Mar 27, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.49M 37,000 shares
$67.39
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $2.84M 53,600 shares
Last Trade
Jan 21, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.44M 29,200 shares
$49.17
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $2.12M 40,000 shares
Last Trade
Jul 17, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.95M 40,000 shares
$48.68
$53.01
Soleno Therapeutics
Soleno Therapeutics SLNO
Chief Commercial Officer
Holding Value $0 0 shares
Last Trade
Apr 22, 2024 Sale
$4.81M 128,000 shares
$37.54
$53.01
Adicet Bio
Adicet Bio ACET
Chief Commercial Officer
Holding Value $204k 26,000 shares
Last Trade
Feb 27, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.55M 26,000 shares
$59.71
$7.83
Adicet Bio
Adicet Bio ACET
Chief Commercial Officer
Holding Value $1.37M 175,000 shares
Last Trade
Sep 17, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$17.1M 175,000 shares
$97.58
$7.83

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up